FI64287B - Foerfarande foer framstaellning av en faerg- och ph-stabil antibiotisk vattenhaltig parenteral produkt av ett farmaceutiskt godtagbart salt av en antibakteriell aminoglykosid - Google Patents

Foerfarande foer framstaellning av en faerg- och ph-stabil antibiotisk vattenhaltig parenteral produkt av ett farmaceutiskt godtagbart salt av en antibakteriell aminoglykosid Download PDF

Info

Publication number
FI64287B
FI64287B FI790086A FI790086A FI64287B FI 64287 B FI64287 B FI 64287B FI 790086 A FI790086 A FI 790086A FI 790086 A FI790086 A FI 790086A FI 64287 B FI64287 B FI 64287B
Authority
FI
Finland
Prior art keywords
solution
aminoglycosides
initial
salt
pharmaceutical
Prior art date
Application number
FI790086A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI790086A (fi
Inventor
Bernard Eli Rosenkrantz
Elliot Isaac Stupak
Original Assignee
Essex Laeaekkeet Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Essex Laeaekkeet Oy filed Critical Essex Laeaekkeet Oy
Publication of FI790086A publication Critical patent/FI790086A/fi
Application granted granted Critical
Publication of FI64287B publication Critical patent/FI64287B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
FI790086A 1978-01-16 1979-01-11 Foerfarande foer framstaellning av en faerg- och ph-stabil antibiotisk vattenhaltig parenteral produkt av ett farmaceutiskt godtagbart salt av en antibakteriell aminoglykosid FI64287B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/869,741 US4223022A (en) 1978-01-16 1978-01-16 Stabilized aminoglycoside antibiotic formulations
US86974178 1978-01-16

Publications (2)

Publication Number Publication Date
FI790086A FI790086A (fi) 1979-07-17
FI64287B true FI64287B (fi) 1983-07-29

Family

ID=25354179

Family Applications (1)

Application Number Title Priority Date Filing Date
FI790086A FI64287B (fi) 1978-01-16 1979-01-11 Foerfarande foer framstaellning av en faerg- och ph-stabil antibiotisk vattenhaltig parenteral produkt av ett farmaceutiskt godtagbart salt av en antibakteriell aminoglykosid

Country Status (24)

Country Link
US (1) US4223022A (de)
EP (1) EP0003150B1 (de)
JP (1) JPS5914447B2 (de)
AR (1) AR223967A1 (de)
AT (1) AT364715B (de)
AU (1) AU524288B2 (de)
BG (1) BG32560A3 (de)
CA (1) CA1129344A (de)
DD (1) DD141410A5 (de)
DE (1) DE2961370D1 (de)
DK (1) DK155306C (de)
ES (1) ES476754A1 (de)
FI (1) FI64287B (de)
GR (1) GR73655B (de)
IE (1) IE48254B1 (de)
IL (1) IL56409A (de)
MY (1) MY8500050A (de)
NO (1) NO153876C (de)
NZ (1) NZ189363A (de)
PH (1) PH18571A (de)
PL (1) PL119296B1 (de)
PT (1) PT69063A (de)
SU (1) SU976837A3 (de)
ZA (1) ZA7962B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4327087A (en) * 1978-01-16 1982-04-27 Schering Corporation Stabilized Netilmicin formulations
HU197514B (en) * 1985-03-07 1989-04-28 Chinoin Gyogyszer Es Vegyeszet Process for production of injection sulution containing acid-additional salts od sysomicin
US5124317A (en) 1985-08-02 1992-06-23 Farmitalia Carlo Erba S.P.A. Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US5977082A (en) 1985-08-02 1999-11-02 Pharmacia & Upjohn Company Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
DE3766984D1 (de) * 1986-03-07 1991-02-07 American Cyanamid Co Stabile injizierbare arzneiformulierung des 1,4-dihydroxy-5,8-bis((2-(hydroxyaethylamino)-aethyl)amino)anthrachinondihydrochlorids.
JPH05236765A (ja) * 1992-02-20 1993-09-10 Okuma Mach Works Ltd ローテータブル・リニア・アクチュエータ
JPH0630206U (ja) * 1992-09-14 1994-04-19 川崎重工業株式会社 締固め機械の安全ガード装置
US5912228A (en) * 1995-01-13 1999-06-15 Xoma Corporation Therapeutic compositions comprising bactericidal/permeability-increasing (BPI) protein products
US7794713B2 (en) 2004-04-07 2010-09-14 Lpath, Inc. Compositions and methods for the treatment and prevention of hyperproliferative diseases
US7862812B2 (en) 2006-05-31 2011-01-04 Lpath, Inc. Methods for decreasing immune response and treating immune conditions

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4911403B1 (de) * 1970-12-29 1974-03-16
US3832286A (en) * 1971-02-03 1974-08-27 Schering Corp Sisomicin and methods for its production
US3995635A (en) * 1971-09-09 1976-12-07 Alza Corporation Ocular insert
US3956068A (en) 1972-07-14 1976-05-11 Schering Corporation Antibiotic G-52 and method for the production thereof
GB1405283A (en) 1972-08-17 1975-09-10 Scherico Ltd Antibiotics and processes for their preparation
US3880828A (en) 1973-02-23 1975-04-29 Schering Corp Antibiotics 66-40B and 66-40D from micromonospora inyoensis
US3962429A (en) * 1973-08-01 1976-06-08 Chugai Seiyaku Kabushiki Kaisha Method for reducing side effects of aminoglycoside antibiotics and composition therefor
US3898330A (en) * 1973-08-01 1975-08-05 Squibb & Sons Inc Corticosteroid phosphate salts/neomycin sulfate ophthalmic
US3944064A (en) * 1973-10-26 1976-03-16 Alza Corporation Self-monitored device for releasing agent at functional rate
US4011390A (en) * 1974-02-15 1977-03-08 Schering-Plough Corporation Semi-synthetic aminocyclitol aminoglycoside antibiotics and methods for the preparation thereof
US4002742A (en) * 1974-03-19 1977-01-11 Schering Corporation 1-N-alkyl-4,6-di-(aminoglycosyl)-1,3-diaminocyclitols, methods for their manufacture, methods for their use as antibacterial agents, and compositions useful therefor
US4009328A (en) * 1975-05-02 1977-02-22 Schering Corporation Aminoglycoside 66-40C, method for its manufacture, method for its use as an intermediate in the preparation of known antibiotics and novel antibacterials
GB1529243A (en) * 1976-02-25 1978-10-18 Pfizer Ltd Process for the preparation of aminoglycoside derivatives and cyclic urethane intermediates for use therein

Also Published As

Publication number Publication date
BG32560A3 (en) 1982-08-16
DE2961370D1 (en) 1982-01-28
NZ189363A (en) 1984-07-06
AR223967A1 (es) 1981-10-15
DD141410A5 (de) 1980-04-30
IL56409A0 (en) 1979-03-12
EP0003150A1 (de) 1979-07-25
FI790086A (fi) 1979-07-17
IE790045L (en) 1979-07-16
CA1129344A (en) 1982-08-10
AT364715B (de) 1981-11-10
PL119296B1 (en) 1981-12-31
JPS5914447B2 (ja) 1984-04-04
ES476754A1 (es) 1979-12-16
NO790085L (no) 1979-07-17
NO153876C (no) 1989-08-22
IE48254B1 (en) 1984-11-14
PT69063A (en) 1979-02-01
AU4332079A (en) 1979-07-26
DK155306C (da) 1989-08-28
PH18571A (en) 1985-08-12
MY8500050A (en) 1985-12-31
DK155306B (da) 1989-03-28
SU976837A3 (ru) 1982-11-23
GR73655B (de) 1984-03-27
NO153876B (no) 1986-03-03
ATA20479A (de) 1981-04-15
PL212809A1 (de) 1980-02-11
DK14579A (da) 1979-07-17
EP0003150B1 (de) 1981-11-25
US4223022A (en) 1980-09-16
IL56409A (en) 1981-09-13
ZA7962B (en) 1979-12-27
AU524288B2 (en) 1982-09-09
JPS54100346A (en) 1979-08-08

Similar Documents

Publication Publication Date Title
FI64287B (fi) Foerfarande foer framstaellning av en faerg- och ph-stabil antibiotisk vattenhaltig parenteral produkt av ett farmaceutiskt godtagbart salt av en antibakteriell aminoglykosid
Williams et al. Studies of crystalline vitamin B1. III. Cleavage of vitamin with sulfite
US20040053888A1 (en) Cyclodextrin-containing pharmaceutical preparation
Formelli et al. Effects of adriamycin on DNA synthesis in mouse and rat heart
Buur et al. Prodrugs of 5-fluorouracil. I. Hydrolysis kinetics and physicochemical properties of various N-acyl derivatives of 5-fluorouracil
WO1991001718A1 (fr) Procede de photostabilisation pour collyre liquide et collyre liquide photostabilise
EP1618894B1 (de) Zusammensetzung zur injektion
RU2219917C2 (ru) Стабильные растворы митоксантрона
CN103467529B (zh) 乙二胺四乙酸双核铂配合物及其制备方法
Naumovich Surface tension and pH of drugs in root canal therapy
BR112019025688A2 (pt) derivados de aminoglicosídeos e seus usos no tratamento de distúrbios genéticos
US4327087A (en) Stabilized Netilmicin formulations
JP2020518608A5 (de)
Saito et al. Similar pharmacokinetics and differential ototoxicity after administration with cisplatin and transplatin in guinea pigs
Oakes et al. Doxorubicin blocks the increase in intracellular Ca++, part of a second messenger system in N1E-115 murine neuroblastoma cells.
Ensminger et al. Thymidine 5′-o-pivaloate: A prodrug derivative of thymidine with potential applications in high-dose methotrexate therapy
MIYAZAKI et al. Dissolution properties of salt forms of berberine
DE3122689C2 (de) N-Trifluoracetyl-adriamycin-14-0-hemiglutarat und -hemiadipat und diese Verbindungen enthaltende pharmazeutische Zubereitungen
WO2000044334A2 (en) Novel injectable muscle relaxant formulations
SE502110C2 (sv) Användning av en moranolinförening, nojirimycin eller castanospermin för framställning av en sammansättning med trombolytisk verkan.
KR100279341B1 (ko) 항악성종양제 독소루비신의 안정한 주사액 및 그 제조방법
Semonsky et al. Antineoplastic Effect of Compound 9777-VUFB in Animals with Experimental Tumours; Its Interaction with Some Cutostatics
ES2294295T3 (es) Formulacion para la administracion parenteral de un bloqueador del canal na.
Bjerregaard Side-specific toxic effects on the membranes of cultured renal epithelial cells (A6)
DE2404931A1 (de) Psychotonikum

Legal Events

Date Code Title Description
FC Application refused

Owner name: ESSEX LAEAEKKEET OY